The American Cancer Society reports that the vaccination for the human papillomavirus (HPV) is highly underutilized despite its known prevention of cervical and other types of genital cancers. Statistics reported by the Centers for Disease Control and Prevention (CDC) show that only 40% of girls and 21% of males have received the entire series of the HPV vaccines. While vaccination hesitancy may be due to the short life of the vaccine, extensive testing has been conducted to conclude the vaccine’s safety and has received approval from the US Food and Drug Administration.
How Providers Can Increase HPV Vaccination Rates
Patients respond positively to healthcare provider recommendations. Speaking to patients about the HPV vaccines, and highlighting the positive outcomes, is the first step in vaccination adoption. Team up with organizations such as the American Cancer Society, which offer healthcare providers tools and training resources for advocating the importance of the HPV vaccines.
To learn more about HPV vaccination rates and the American Cancer Society’s Vaccinate Adolescents against Cancer (VACs) program, read more here>.
Read more tips for advocating immunizations to patients here>.